Table 6 Comparison of MLV sequences amplified from patient samples with mouse genomic sequences
From: No evidence of XMRV in prostate cancer cohorts in the Midwestern United States
Sequence (GenBank no.) | Length (nt) | Closest relative | GenBank no. | Similarity | Nucleotide difference |
|---|---|---|---|---|---|
51_PCR_LF2_GagR (JF288878) | 608 | Mus musculus BAC clone RP23-457E5 | AC121813 | 100% | 0/608 |
51_PCR_LF3_GagR (JF288879) | 250 | Mus musculus chrom 7, clone RP24-220N8 | AC167466 | 99% | 1/250 |
15_PCR_LF2_GagR (JF288880) | 608 | Mus musculus BAC clone RP23-152O2 | AC163634 | 100% | 0/608 |
15_PCR_LF3_GagR (JF288881) | 271 | Mus musculus BAC clone RP23-152O2 | AC163634 | >99% | 1/271 |
52_PCR_GagF_GagR (JF288882) | 525 | Mouse DNA sequence, clone CH29-187G15 | CU407131 | 100% | 0/525 |
52_PCR_LF2_GagR (JF288883) | 540 | Mus musculus chrom 5, clone RP23-280N22 | AC123679 | >99% | 1/540 |
112_PCR_LF2_GagR (JF288884) | 691 | Mouse DNA sequence, CH29-187G15 | CU407131 | >99% | 6/691 |